Prosecution Insights
Last updated: April 19, 2026

Tilt Biotherapeutics OY

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17956923 Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto SINGH, ANOOP KUMAR 1632 Non-Final OA Sep 30, 2022
17767945 An oncolytic virus vector coding for variant interleukin-2 (vIL-2) polypeptide MATALKAH, FATIMAH KHALAF 1638 Final Rejection Apr 11, 2022
17618932 Oncolytic adenovirus and checkpoint inhibitor combination therapy PATTERSON, SARAH COOPER 1675 Final Rejection Dec 14, 2021

Managing Tilt Biotherapeutics OY's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month